← back to search

Lionel Couzi

Université de Rouen Normandie · FR
Area of research
Transplantation · Epidemiology
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Cytomegalovirus and herpesvirus research, Renal Diseases and Glomerulopathies, and Immune Cell Function and Interaction.
h-index
52
citations
9,698
works
307
NIH funding
primary concept
Medicine
email

Recent publications

Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models.
2026cited by 0position: contributordoi
Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation.
2026cited by 0position: contributordoi
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infection.
2026cited by 0position: contributordoi
Anticytomegalovirus immunotoxin during ex vivo machine perfusion: Are we ready for cytomegalovirus-negative transplantation?
2026cited by 0position: contributordoi
Spiroplasma infection complicated by macrophage activation syndrome and fulminant hepatitis in a kidney transplant recipient
American Journal of Transplantation 2026cited by 0position: contributordoi
Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international study
American Journal of Transplantation 2025cited by 10position: middledoi
Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international study
American Journal of Transplantation 2025cited by 10position: contributordoi
Detection of Kidney Allograft Rejection Using Urinary Chemokines
Journal of the American Society of Nephrology 2025cited by 7position: middledoi
Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
2025cited by 3position: contributordoi
Detection of Kidney Allograft Rejection Using Urinary Chemokines.
2025cited by 2position: contributordoi
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
New England Journal of Medicine 2024cited by 50position: middledoi
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection
Clinical Transplantation 2024cited by 19position: middledoi
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients
Kidney International 2024cited by 17position: middledoi
Estimating glomerular filtration in young people
Clinical Kidney Journal 2024cited by 16position: middledoi
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
2024cited by 13position: contributordoi
Intrinsic capacity and frailty in older adults with end-stage kidney disease undergoing pre-kidney transplant comprehensive geriatric assessment
The Journal of nutrition, health and aging 2024cited by 8position: contributordoi
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017.
2024cited by 7position: contributordoi
Estimating glomerular filtration in young people.
2024cited by 6position: contributordoi
Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies
Transplant International 2024cited by 5position: middledoi
The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation.
2024cited by 2position: contributordoi
Epidemiology of <i>Campylobacter</i> Species Infection in Kidney Transplant Recipients: A Retrospective Multicentric Case-Control Study in France.
2024cited by 1position: contributordoi
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa.
2023cited by 65position: contributordoi
An automated histological classification system for precision diagnostics of kidney allografts
Nature Medicine 2023cited by 53position: middledoi
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance.
2023cited by 9position: contributordoi
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa
Nephrology Dialysis Transplantation 2022cited by 88position: middledoi
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Transplant Infectious Disease 2022cited by 43position: middledoi
Alloimmune Risk Stratification for Kidney Transplant Rejection
Transplant International 2022cited by 34position: middledoi
Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation
Science Translational Medicine 2022cited by 27position: middledoi
Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation.
2022cited by 21position: contributordoi
WARS1, TYMP and GBP1 display a distinctive microcirculation pattern by immunohistochemistry during antibody-mediated rejection in kidney transplantation.
2022cited by 11position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 30 papers (2020–2026)Nassim Kamar · French Clinical Research Infrastructure Network11 papers (2014–2025)Lionel Rostaing · Grenoble Institute of Neurosciences9 papers (2014–2024)Christophe Legendre · Hôpital Necker-Enfants Malades7 papers (2018–2024) · 7 papers (2021–2025)Sophie Caillard · Nantes Université6 papers (2018–2024)Hans Pottel · KU Leuven5 papers (2019–2024)Dany Anglicheau · Sorbonne Paris Cité5 papers (2021–2026)Olivier Thaunat · Lyon College5 papers (2021–2022)Hannah Kaminski · Elsevier, Inc.5 papers (2020–2026)Pierre Merville · Mayne Pharma (Australia)4 papers (2021–2026) · 4 papers (2021–2024) · 4 papers (2021–2024)Jonathan Visentin · Centre National de la Recherche Scientifique4 papers (2022–2022)Marie Courbebaisse · Laboratoire National de Référence3 papers (2018–2024)Véronique Frémeaux‐Bacchi · Délégation Paris 53 papers (2012–2018) · 3 papers (2014–2019)Claudia Kemper · National Institutes of Health3 papers (2012–2018)Cyril Garrouste · Hôpital Saint-Jacques3 papers (2018–2024)Pierre Delanaye · Hôpital Bichat-Claude-Bernard3 papers (2018–2024)